celecoxib has been researched along with Lymphoma, Large B-Cell, Diffuse in 2 studies
Lymphoma, Large B-Cell, Diffuse: Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El Bary, NA | 1 |
| Hashem, T | 1 |
| Metwally, H | 1 |
| Ghany, AA | 1 |
| El Mageed, HA | 1 |
| Bosch, R | 1 |
| Dieguez-Gonzalez, R | 1 |
| Céspedes, MV | 1 |
| Parreño, M | 1 |
| Pavón, MÁ | 1 |
| Grañena, A | 1 |
| Sierra, J | 1 |
| Mangues, R | 1 |
| Casanova, I | 1 |
1 trial available for celecoxib and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
A phase II study of high-dose celecoxib and metronomic 'low-dose' cyclophosphamide and methotrexate in patients with relapsed and refractory lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cyclooxygenase 2 Inhibitors; Cyclophospha | 2010 |
1 other study available for celecoxib and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
A novel inhibitor of focal adhesion signaling induces caspase-independent cell death in diffuse large B-cell lymphoma.
Topics: Animals; Antineoplastic Agents; Caspases; Celecoxib; Cell Death; Cell Line, Tumor; Crk-Associated Su | 2011 |